trapidil has been researched along with Peripheral Vascular Diseases in 2 studies
Trapidil: A coronary vasodilator agent.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trapidil has shown a more complete antithrombocytic activity than other antiaggregating drugs; as a matter of fact it inhibits the formation of TXA2 through a mechanism of receptorial antagonism and at the same time it favours an increase of prostacyclina from the arterial walls." | 2.38 | [Trapidil after one year]. ( Agus, GB, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonfardeci, G | 1 |
| Cimminiello, C | 1 |
| Cantini, L | 1 |
| Arpaia, G | 1 |
| Aloisio, M | 1 |
| Pozzi, F | 1 |
| Agus, GB | 1 |
1 review available for trapidil and Peripheral Vascular Diseases
| Article | Year |
|---|---|
[Trapidil after one year].
Topics: Anticoagulants; Arm; Arteriosclerosis; Brain Ischemia; Clinical Trials as Topic; Drug Evaluation; Hu | 1993 |
1 trial available for trapidil and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Platelet and endothelial response with trapidil in patients with peripheral obliterative arteriopathy.
Topics: Aged; Arteriosclerosis; Blood Platelets; Double-Blind Method; Endothelins; Endothelium, Vascular; Fe | 1994 |